Core Insights - The sixth Biomanufacturing Industry Conference was held in Shenzhen, showcasing China's strength in biomanufacturing and innovation density in the region [2][4] - The conference revealed the "Top Ten New Products" for 2025, covering various fields such as pharmaceuticals, materials, and consumer goods, highlighting the market potential of synthetic biology technology [5] Regulatory Developments - Shenzhen's new legislation, "Regulations on Promoting Innovation and Development of the Synthetic Biology Industry," aims to shorten product pre-testing cycles and reduce production costs for enterprises [3] - The legislation is designed to address the actual needs of the synthetic biology industry and improve the business environment [3] Industry Collaboration - The conference emphasized the importance of collaborative innovation within the Guangdong-Hong Kong-Macao Greater Bay Area, leveraging Hong Kong's advantages in international standards and cross-border financial services [3] - The establishment of the National Biomanufacturing Industry Innovation Center marks a significant step in integrating technology and industry innovation [5] Achievements and Statistics - Shenzhen has over 400 biomanufacturing companies, with 160 new firms established in the last three years, 80% of which chose the Guangming Science City as their location [4] - The city leads the nation in patent applications for biomanufacturing, indicating a high density of industry resources [5] New Initiatives - The DIKI Biomanufacturing Industry Intelligent Analysis Platform was launched, providing a comprehensive data set for government and business decision-making [5] - The conference also featured thematic forums exploring diverse technological routes and business models in biomanufacturing [6]